{"id":"W4391424613","doi":"10.1055/a-2259-0662","title":"Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low-Molecular-Weight Heparin: The OSCAR-UK Study","year":2024,"lang":"en","type":"article","venue":"Thrombosis and Haemostasis","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa; Ottawa Hospital; University of British Columbia","funders":"Janssen Pharmaceuticals; Janssen Research and Development; LEO Pharma; Bristol-Myers Squibb; AstraZeneca; CSL Behring; Alexion Pharmaceuticals; Daiichi Sankyo Europe; Sanofi; Bayer; Servier; Daiichi-Sankyo; Pfizer","keywords":"Medicine; Rivaroxaban; Low molecular weight heparin; Venous thromboembolism; Cancer; Heparin; Internal medicine; Major bleeding; Population; Intensive care medicine; Thrombosis; Surgery; Warfarin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003968764,0.0008501294,0.001891766,0.001476543,0.0004367385,0.001199101,0.0013182,0.001163775,0.002553845],"category_scores_gemma":[0.01002603,0.0005820176,0.00299873,0.0020079,0.0005563242,0.001070826,0.001825245,0.0009068755,0.0005469134],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00111347,"about_ca_system_score_gemma":0.0006532211,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00638672,"about_ca_topic_score_gemma":0.005789587,"domain_scores_codex":[0.994091,0.002586415,0.0009271213,0.001145256,0.0007581032,0.0004921803],"domain_scores_gemma":[0.9906181,0.001854285,0.004934986,0.0008975766,0.0007040967,0.0009910823],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.01212975,0.0002071811,0.9804366,0.0002580122,0.002457636,0.0001869564,0.0001552663,0.0002790471,0.00020272,0.000108574,0.0008893071,0.002688913],"study_design_scores_gemma":[0.002020897,0.002328922,0.9918329,0.0001160875,0.001083355,0.000491633,0.0002704293,0.0005045439,0.00008169236,0.00008418265,0.001143283,0.00004200661],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938951,0.002374443,0.0001858668,0.00008811595,0.00004332682,0.00008228386,0.002747499,0.000005078015,0.0005781578],"genre_scores_gemma":[0.9939641,0.0006061881,0.0001378818,0.0001094045,0.0000435234,0.0001087022,0.004770975,0.000008148214,0.000251125],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00638672,"threshold_uncertainty_score":0.02098906,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08110310117406964,"score_gpt":0.4339794015787528,"score_spread":0.3528763004046831,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}